The BCRT is an internationally recognized center with a strong interdisciplinary program with basic research, clinical research areas and enabling technologies being closely linked within an innovative translational infrastructure (business development, regulatory affairs, health economy).
The BCRT was founded in 2006 as an alliance between the Charité - Universitätsmedizin Berlin, one of Europe's largest university clinics, and the Helmholtz Association, Germany's largest research association. A team of over 250 employees- including physicians, scientists, engineers, experts in translational medicine, PhD students and technical staff - are conducting research at the BCRT's two sites: at the Cranach building on the Virchow Clinic Campus of the Charité, with its close links to the BCRT partner clinics, and at the Teltow Campus of the Helmholtz Centre Geesthacht, the Centre for Biomaterial Development.
After 12 successful years, the alliance of "Berlin-Brandenburg Centre for Regenerative Therapies (BCRT)" was consolidated in 2019.
The Charité part of the integration has now become a separate research focus within the "Berlin Institute of Health (BIH)" and is renamed the "BIH Centre for Regenerative Therapies".
The Helmholtz part was also successfully consolidated.
This however does not mean an end to the long-standing and close cooperation between the two institutions, which will continue in the future.